Protagonist Therapeutics PTGX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's operating lease right-of-use assets in other assets?
- Protagonist Therapeutics (PTGX) reported operating lease right-of-use assets in other assets of $7.39M in Q1 2026.
- How has Protagonist Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Protagonist Therapeutics's operating lease right-of-use assets in other assets decreased by 17.9% year-over-year, from $9M to $7.39M.
- What is the long-term trend for Protagonist Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's operating lease right-of-use assets in other assets has grown at a 9.6% compound annual growth rate (CAGR), from $4.95M to $7.83M.